Ledger.Open graph →
SEC Form D · filed March 1, 2023

Ascend Gene & Cell Therapies Ltd

Offering
$66.6M
Sold
$66.6M
Exemption
Rule 506(b)
Industry
Other
Location
ALTRINCHAM, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Timothy Funnell · Altrincham, United KingdomExec · DirectorMichael Beecham · Altrincham, United KingdomDirectorFred Cohen · Menlo Park, CADirectorEric Shiozaki · San Diego, CADirectorBalaji Muralidhar · Campbell, CADirectorAndrew Sinclair · Altrincham, United KingdomDirectorAndrew May · Altrincham, United KingdomDirectorTimothy Funnell · Altrincham, United KingdomExec · DirectorMichael Beecham · Altrincham, United KingdomDirectorFred Cohen · Menlo Park, CADirectorEric Shiozaki · San Francisco, CADirectorBalaji Muralidhar · Campbell, CADirectorAndrew Sinclair · Altrincham, United KingdomDirectorAndrew May · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗